Drug intelligence / Profile preview

19(R)-hydroxyprostaglandin E2

Development stage
Unknown
Lead developer
Cayman Chemical
Modality
Small Molecules
01

Overview

19(R)-hydroxyprostaglandin E2 is a naturally occurring lipid mediator and an analog of Prostaglandin E2 (PGE2), primarily identified in the semen of primates, including humans. It functions as a potent and selective agonist for the Prostaglandin E2 receptor EP2 subtype. As a small molecule, it is widely utilized as a chemical research tool to investigate the physiological and pathological roles of the EP2 receptor pathway, particularly its involvement in smooth muscle relaxation, inflammation, vascular tone regulation, and immune response modulation. The compound is commercialized by specialized chemical suppliers such as Cayman Chemical and MedChemExpress for laboratory research purposes only and is not approved for human or veterinary therapeutic applications.

Other names
19(R)-hydroxy PGE219(R)-OH PGE211α,15S,19R-trihydroxy-9-oxo-prosta-5Z,13E-dien-1-oic acid19(R)-hydroxy-PGE2
02

Targets

PTGER2 (Prostaglandin E2 receptor EP2)

Beyond the preview

Go deeper on 19(R)-hydroxyprostaglandin E2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 19(R)-hydroxyprostaglandin E2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call